Thomas Scheier
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 5
- HIV/AIDS drug development and treatment 4
- HIV/AIDS Research and Interventions 4
- SARS-CoV-2 detection and testing 3
- General Dentistry top 10%
-
- COVID-19 epidemiological studies 3
-
- Burn Injury Management and Outcomes 3
-
- Biosensors and Analytical Detection 3
- Co-authors
- Silvio D. BruggerPhilipp K. BuehlerPeter W. SchreiberDaniel A. HofmaennerReto A. SchuepbachHuldrych F. GünthardDominique L. BraunJürg Böni
- Partner nations
- SwitzerlandCanadaUnited Kingdom
In The Last Decade
Thomas Scheier
30 papers receiving 244 citations
Peers
Comparison fields: 5 of 67
- Infectious Diseases 144
- General Dentistry 11
- Virology 20
- Modeling and Simulation 17
- Immunology 37
Countries citing papers authored by Thomas Scheier
This map shows the geographic impact of Thomas Scheier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Scheier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Scheier more than expected).
Fields of papers citing papers by Thomas Scheier
This network shows the impact of papers produced by Thomas Scheier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Scheier. The network helps show where Thomas Scheier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Scheier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 19 | |
| 15 | 2022 | 6 | |
| 16 | 2021 | 11 | |
| 17 | 2021 | 35 | |
| 18 | 2021 | 18 | |
| 19 | 2021 | 4 | |
| 20 | 2021 | 5 |
About Thomas Scheier
Thomas Scheier is a scholar working on Infectious Diseases, Modeling and Simulation and Critical Care and Intensive Care Medicine, having authored 33 papers that have together received 249 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), HIV/AIDS drug development and treatment (4 papers), HIV/AIDS Research and Interventions (4 papers), Burn Injury Management and Outcomes (3 papers), Biosensors and Analytical Detection (3 papers), COVID-19 epidemiological studies (3 papers) and SARS-CoV-2 detection and testing (3 papers). The work is most often cited by research in Infectious Diseases (144 citations), General Dentistry (11 citations) and Virology (20 citations). Thomas Scheier has collaborated with scholars based in Switzerland, Canada and United Kingdom. Frequent co-authors include Silvio D. Brugger, Philipp K. Buehler, Peter W. Schreiber, Daniel A. Hofmaenner, Reto A. Schuepbach, Huldrych F. Günthard, Dominique L. Braun, Jürg Böni, Pascal M. Frey and Irène A. Abela. Their work appears in journals such as Journal of Hospital Infection, iScience, Burns, Emerging infectious diseases and Antimicrobial Resistance and Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.